Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis (Q37220313)

19 August 2017

Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis (English)

1 reference

19 August 2017

0 references

1 reference

Pseudomonas aeruginosa

1 reference

A E Hollsing

1

1 reference

19 August 2017

M Granström

2

1 reference

19 August 2017

M L Vasil

3

1 reference

19 August 2017

B Wretlind

4

1 reference

19 August 2017

B Strandvik

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

Journal of Clinical Microbiology

19 August 2017

1 reference

19 August 2017

25

1 reference

19 August 2017

10

1 reference

19 August 2017

1868-1874

1 reference

Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Influence of Iron on Yields of Extracellular Products in Pseudomonas aeruginosa Cultures

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Antibiotic use in cystic fibrosis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Cystic Fibrosis—A Challenging Long-Term Chronic Disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269358

Respiratory studies in children. IX. Relationships between mechanical properties of the lungs, lung volumes and ventilatory capacity in healthy children 7-15 years of age

3 September 2018

1 reference

12 December 2020

Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis

1 reference

12 December 2020

Biochemical and genetic studies of iron-regulated (exotoxin A) and phosphate-regulated (hemolysin phospholipase C) virulence factors of Pseudomonas aeruginosa

1 reference

12 December 2020

Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins

1 reference

12 December 2020

Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A

1 reference

12 December 2020

Distinguishing complicated from uncomplicated bacteremia caused by Staphylococcus aureus: the value of "new" and "old" serological tests

1 reference

12 December 2020

Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis

1 reference

12 December 2020

Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis

1 reference

12 December 2020

Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis

1 reference

12 December 2020

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

12 December 2020

Identifiers

1 reference

19 August 2017

1 reference